Addvise logo
sv_SE
sv_SE
search

Invitation to presentation of year-end report January 1 – December 31, 2023

08-02-2024   Non-regulatory press release

ADDvise Group’s year-end report for the period January 1 – December 31, 2023 will be published on February 22, 2024 at 07:45 (CET).

Investors, analysts and other stakeholders are invited to a webcast and conference call at 14:00 (CET) / 08:00 AM (ET) the same day where CEO Rikard Akhtarzand and CFO Oliver Humlen will present the report.

 

Webcast

If you wish to participate via webcast, please use the link below.

 

https://ir.financialhearings.com/addvise-group-q4-2023/register

 

Conference call

If you wish to participate via conference call, please register via the link below. After registration you will receive a phone number and conference ID to access the conference.

 

https://conference.financialhearings.com/teleconference/?id=5007160

 

The report and a link to the webcast will be made available on:

 

https://www.addvisegroup.com/investor-relations/

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

Oliver Humlen, CFO
+46 709-16 26 97
oliver.humlen@addvisegroup.se

About ADDvise Group


ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The Group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expanding the business - both geographically and product-wise. ADDvise Group's shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

Latest press releases

ADDvise publishes prospectus in connection with a rights issue

 Regulatory

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES), AUSTRALIA, CANADA, BELARUS, HONG KONG, JAPAN, NEW ZEALAND AND RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL,…

Report from the extra ordinary general meeting in ADDvise Group AB (publ)

 Regulatory

ADDvise Group AB (publ), reg. no. 556363-2115 (the "Company"), has held an extraordinary general meeting on 12 March 2025. The general meeting resolved to amend the articles of association, approve the board's resolution regarding a rights issue of shares of series A and series B, approve the board's resolution on a directed issue of warrants…

Year-end report 2024, January 1–December 31

 Regulatory

The fourth quarter of 2024 showed a turnaround in organic net revenue. In December alone, we are now back at positive organic growth of 4.8%. With new long-term financial targets, we are now taking the next step in the company’s development, with a continued focus on profitable growth, stable returns and well-balanced debt.

Notice to extraordinary general meeting of ADDvise Group AB (publ)

 Regulatory

ADDvise Group AB (publ), reg. no 556363–2115, hereby convenes the extraordinary general meeting on 12 March 2025 at 10:00 CET at Grev Turegatan 30 in Stockholm. Entrance and registration start at 09:30 CET. Shareholders wishing to attend the general meeting must: i)          be registered in the share register kept by Euroclear Sweden on the record…